Should atrial fibrillation be considered a cardiovascular risk factor for a worse prognosis in COVID-19 patients?

Eur Heart J. 2020 Jul 1;41(32):3092-3093. doi: 10.1093/eurheartj/ehaa509.

Authors

Fabian Sanchis-Gomar^{1

2}, Carme Perez-Quilis¹, Carl J Lavie³

Affiliations

¹ Department of Physiology, Faculty of Medicine, University of Valencia and INCLIVA Biomedical Research Institute, Valencia, Spain.
² Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, USA.
³ John Ochsner Heart and Vascular Institute, Ochsner Clinical School - The University of Queensland School of Medicine, New Orleans, LA, USA.

No abstract available

Publication types

Comment

MeSH terms

Atrial Fibrillation*
Betacoronavirus
COVID-19
Cardiovascular Diseases*
Coronavirus Infections*
Humans
Italy
Pandemics*
Pneumonia, Viral*
Prognosis
Risk Factors
SARS-CoV-2